- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Menu
Aliquots are pre-aliquoted, commercially available drugs from the EU. Our aliquots thus contain therapeutic molecules manufactured by the original drug license holder and repackaged by Evidentic.
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
|---|---|---|---|---|---|---|---|---|---|---|
VEGF-A |
Monoclonal Antibody |
Vegzelma® |
25 mg/mL |
– |
2 mg |
tba |
tba |
198,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2018.06 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2018.09 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2018.09 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2018.12 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2019.03 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2019.08 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
2 mg |
-80°C |
2019.10 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
yes |
2 mg |
-80°C |
2021.03 |
212,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
3 mg |
-80°C |
2017.09 |
267,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
3 mg |
-80°C |
2018.03 |
267,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
– |
12.5 mg |
-80°C |
2024.06 |
367,00 € |
||
VEGF-A |
Monoclonal Antibody |
Avastin® |
25 mg/mL |
yes |
2 mg |
-80°C |
2024.07 |
212,00 € |
||
CD19 , CD3 |
Bispecific Antibody |
Blincyto® |
0,0125 mg/mL |
– |
0,002 mg |
-80°C |
2027.07 |
1.051,00 € |
||
IL-17RA |
Monoclonal Antibody |
Kyntheum® |
140 mg/mL |
– |
7 mg |
-80°C |
2022.05 |
295,00 € |
||
IL-1 beta |
Monoclonal Antibody |
Ilaris® |
150 mg/mL |
– |
4.5 mg |
-80°C |
2025.07 |
2.512,00 € |
||
IL-1 beta |
Monoclonal Antibody |
Ilaris® |
150 mg/mL |
– |
4.5 mg |
-80°C |
2025.07 |
2.512,00 € |
||
TNF alpha |
Antibody Fab'fragment |
Cimzia® |
200 mg/mL |
– |
8 mg |
-80 °C |
2022.09 |
274,00 € |
||
TNF alpha |
Antibody Fab'fragment |
Cimzia® |
200 mg/mL |
– |
8 mg |
-80 °C |
2025.03 |
274,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
2019.11 |
197,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
2020.01 |
197,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
2021.05 |
197,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
5 mg |
-80°C |
2021.09 |
329,00 € |
||
EGFR |
Monoclonal Antibody |
Erbitux® |
5 mg/mL |
– |
2 mg |
-80°C |
2021.11 |
197,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
2 mg |
-80°C |
2018.11 |
242,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
2 mg |
-80°C |
2019.05 |
242,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
4 mg |
-80°C |
2023.11 |
354,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
4 mg |
-80°C |
2024.11 |
354,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
2 mg |
-80°C |
2018.01 |
242,00 € |
||
CD38 |
Monoclonal Antibody |
Darzalex® |
20 mg/mL |
– |
3 mg |
-80°C |
2018.04 |
304,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany
